What is the most cost-effective population-based cancer screening program for Chinese women?

Journal of Clinical Oncology

Volumn 25, Issue 6, 2007, Pages 617-624

  Woo, Pauline P S ^a   Kim, Jane J ^a   Leung, Gabriel M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BUDGET; CANCER; CANCER SCREENING; CHINESE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MEDICAL PARAMETERS; MODEL; OCCULT BLOOD TEST; PAPANICOLAOU TEST; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; STOCHASTIC MODEL; UNCERTAINTY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; AGE; ASIAN; BREAST TUMOR; COHORT ANALYSIS; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE QUALITY; HEALTH SURVEY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MONTE CARLO METHOD; OCCULT BLOOD; ORGANIZATION AND MANAGEMENT; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; STATISTICS; SURVIVAL; UTERINE CERVIX TUMOR; VAGINA SMEAR; WOMEN'S HEALTH;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HONG KONG; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MONTE CARLO METHOD; OCCULT BLOOD; POPULATION SURVEILLANCE; PROBABILITY; PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 33947605782     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.0210     Document Type: Article

References (34)

1. Neuman PJ, Rosen AB, Weinstein MC: Medicare and cost-effectiveness analysis. N Engl J Med 353:1516-1522, 2005
2. Oregon Health Services Commission: Oregon Medicaid priority setting project. Portland, OR, Oregon State Government, 1991
3. Jamison DT, Mosley WH, Measham AR, et al: Disease Control Priorities in Developing Countries. New York, NY, Oxford University Press, 1993
4. Tengs TO, Adams ME, Pliskin JS, et al: Five-hundred life-saving interventions and their costeffectiveness. Risk Anal 15:369-390, 1995
5. Murray CJL, Evans DB, Acharya A, et al: Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9:235-251, 2000
6. Evans DB, Adam T, Tan-Torres Edejer T, et al: Time to reassess strategies for improving health in developing countries. BMJ 331:1133-1136, 2005
7. Evans DB, Tan-Torres Edejer T, Adam T, et al: Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 331:1137-1140, 2005
8. Evans DB, Lim SS, T Adam T, et al: Evaluation of current strategies and future priorities for improving health in developing countries. BMJ 331:1457-1461, 2005
9. Adam T, Lim SS, Mehta S, et al: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ 331:1107, 2005
10. Tan-Torres Edejer T, Aikins M, Black R, et al: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies for child health in developing countries. BMJ 331:1177, 2005
11. Morel CM, Lauer JA, Evans DB, et al: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 331:1299, 2005
12. Baltussen R, Floyd K, Dye C: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 331:1364, 2005
13. Hogan DR, Baltussen R, Hayashi C, et al: Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 331:1431-1437, 2005
14. Hunink M, Glasziou P, Siegel J, et al: Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge, United Kingdom, Cambridge University Press, 2001
15. International Agency for Research on Cancer Working Group on Evaluation of Cervical Cancer Screening Programs: Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ 293:659-664, 1986
16. Humphrey LL, Helfand M, Chan BKS: Breast cancer screening: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 137:347-360, 2002
17. Pignone M, Rich M, Teutsch SM, et al: Screening for colorectal cancer in adults at average risk: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 137:132-141, 2002
18. Cancer Expert Working Group on Cancer Prevention and Screening.Report of Cancer Expert Working Group on Cancer Prevention and Screening. Hong Kong, People's Republic of China, Department of Health, Government of the Hong Kong Special Administrative Region, 2004
19. Murray CJ, Lopez AD: Quantifying disability: Data, methods and results. Bull World Health Organ 72:481-494, 1994
20. Murray CJ, Lopez AD, Jamison DT: The global burden of disease in 1990: Summary results, sensitivity analysis and future directions. Bull World Health Organ 72:495-509, 1994
21. Hong Kong Census and Statistics Department: Hong Kong life tables 1996-2031. Hong Kong, People's Republic of China, Government of the Hong Kong Special Administrative Region, Government Printers, 2004
22. Mathers CD, Bernard C, Iburg K, et al: The Global Burden of Disease in 2002: Data Sources, Methods and Results. Geneva, Switzerland, WHO, 2003
23. Hong Kong Census and Statistics Department: 2001 population census: Main report. Hong Kong, People's Republic of China, Government of the Hong Kong Special Administrative Region, Government Printers, 2001
24. Hospital Authority: List of charges: S.S. No. 4 to Gazette No. 44/1996. Hong Kong, People's Republic of China, Government Printers, 1996, 2003
25. Hospital Authority: Patient-related group (PRG) costing for breast and rectum cancers (1998/99), cervical cancer (1999/2000). Hong Kong, People's Republic of China, Government of the Hong Kong Special Administrative Region, 2001
26. Tan Torres-Edejer T, Baltussen R, Adam T, et al: Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, Switzerland, WHO, 2003
27. University of Hong Kong: Population health survey report. commissioned by Department of Health. Hong Kong, People's Republic of China, Government of the Hong Kong Special Administrative Region, 2005
28. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792, 2005
29. Leung GM, Thach TQ, Lam TH, et al: Trends in breast cancer incidence in Hong Kong between 1973 and 1999: An age-period-cohort analysis. Br J Cancer 87:982-988, 2002
30. Leung GM, Thach TQ, Chan E, et al: Shortterm, medium-term, long-term and lifetime risks of developing and dying of breast cancer in a Westernised Chinese population: Evidence from Hong Kong between 1976 and 2000. Cancer 103:501-508, 2005
31. Leung GM, Lam TH, Thach TQ, et al: Will screening mammography in the East do more harm than good? Am J Public Health 92:1841-1846, 2002
32. Schoenfeld P, Cash B, Flood A, et al: Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352:2061-2068, 2005
33. Adab P, McGhee SM, Yanova J, et al: The pattern of cervical cancer screening in Hong Kong. Hong Kong, People's Republic of China, Health Services Research Committee/Health Care and Promotion Fund Report, 2001
34. Wong BC, Chan AO, Wong KW, et al: A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong. Eur J Cancer Prev 14:181-184, 2005